May 2012 – A study published in the Annals of Oncology revealed that, of the 20 female participants who received Taxotere, 19 developed permanent hair loss. One participant who was being treated for recurrent breast cancer had previously undergone chemotherapy with a different drug and had complete hair regrowth, but after using Taxotere, she suffered from permanent hair loss.
Reference: “Taxotere Lawsuit – Permanent Hair Loss and Illegal Marketing.” Drugwatch.com, 20 Apr. 2020, www.drugwatch.com/taxotere/lawsuits/